Covered recipient · General Payments record
SUSANNE BODINE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$5,759.92
- Reported across 277 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $966.77 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| DEXCOM, INC. | $428.95 | 13 |
| Lilly USA, LLC | $299.87 | 11 |
| Novo Nordisk AS | $74.58 | 4 |
| Neurocrine BioSciences, Inc. | $26.75 | 1 |
| Amgen Inc. | $25.73 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $22.27 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.63 | 1 |
| Alexion Pharmaceuticals, Inc. | $19.15 | 1 |
| Corcept Therapeutics | $17.50 | 1 |
| SANOFI-AVENTIS U.S. LLC | $16.19 | 1 |
| Verity Pharmaceuticals Inc. | $16.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $19.15 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093944089 | CMS |
| Amgen Inc. | $25.73 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117205647 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.63 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118050113 | CMS |
| Corcept Therapeutics | $17.50 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117728930 | CMS |
| Dexcom, Inc. | $25.16 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153388359 | CMS |
| Dexcom, Inc. | $23.23 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153388361 | CMS |
| Dexcom, Inc. | $44.05 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153388363 | CMS |
| Dexcom, Inc. | $115.22 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153388365 | CMS |
| Dexcom, Inc. | $24.20 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153388367 | CMS |
| Dexcom, Inc. | $36.98 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153388369 | CMS |
| Dexcom, Inc. | $24.10 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153388371 | CMS |
| Dexcom, Inc. | $32.15 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153388377 | CMS |
| Dexcom, Inc. | $20.47 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153388375 | CMS |
| Dexcom, Inc. | $16.58 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153388373 | CMS |
| Dexcom, Inc. | $24.11 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153388381 | CMS |
| Dexcom, Inc. | $23.43 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153388379 | CMS |
| Dexcom, Inc. | $19.27 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153388383 | CMS |
| Lilly USA, LLC | $12.60 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135958001 | CMS |
| Lilly USA, LLC | $14.94 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135893303 | CMS |
| Lilly USA, LLC | $13.48 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135957999 | CMS |
| Lilly USA, LLC | $124.99 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135869419 | CMS |
| Lilly USA, LLC | $19.61 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135949786 | CMS |
| Lilly USA, LLC | $19.39 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135918468 | CMS |
| Lilly USA, LLC | $18.76 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135961281 | CMS |
| Lilly USA, LLC | $19.36 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135918466 | CMS |
| Lilly USA, LLC | $19.36 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135869415 | CMS |
| Lilly USA, LLC | $16.02 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135893300 | CMS |
| Lilly USA, LLC | $21.36 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135957619 | CMS |
| Neurocrine Biosciences, Inc. | $26.75 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150948781 | CMS |
| Novartis Pharmaceuticals Corporation | $22.27 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086778273 | CMS |
| Novo Nordisk Inc | $20.62 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100437569 | CMS |
| Novo Nordisk Inc | $14.59 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100357002 | CMS |
| Novo Nordisk Inc | $14.78 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100494327 | CMS |
| Novo Nordisk Inc | $24.59 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100275880 | CMS |
| SANOFI-AVENTIS U.S. LLC | $16.19 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139902498 | CMS |
| Verity Pharmaceuticals Inc. | $16.15 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1080616534 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.